mTORC1 signaling in primary central nervous system lymphoma
Saved in:
Published in: | Surgical neurology international Vol. 7; no. 18; pp. 475 - S480 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
India
Medknow Publications & Media Pvt Ltd
2016
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Author | Nakasu, Satoshi Nozaki, Kazuhiko Shima, Ayako Nitta, Naoki |
---|---|
AuthorAffiliation | Department of Neurosurgery, Shiga University of Medical Science, Otsu, Japan 1 Department of Neurosurgery, Kusatsu General Hospital, Shiga, Japan 2 Department of Neurosurgery, Koto Memorial Hospital, Shiga, Japan |
AuthorAffiliation_xml | – name: 2 Department of Neurosurgery, Koto Memorial Hospital, Shiga, Japan – name: Department of Neurosurgery, Shiga University of Medical Science, Otsu, Japan – name: 1 Department of Neurosurgery, Kusatsu General Hospital, Shiga, Japan |
Author_xml | – sequence: 1 givenname: Naoki surname: Nitta fullname: Nitta, Naoki – sequence: 2 givenname: Satoshi surname: Nakasu fullname: Nakasu, Satoshi – sequence: 3 givenname: Ayako surname: Shima fullname: Shima, Ayako – sequence: 4 givenname: Kazuhiko surname: Nozaki fullname: Nozaki, Kazuhiko |
BookMark | eNpVkNFrwjAQxsNwTOd832P-gbpLYpKGwWDI3AaCMNxzuKapdrSpNCr0v59Fke1e7viO-_jud08GoQmekEcG0xkD8cSZ5IlOQU1ZKnXKbsjoKg3-zEMyifEHTiUEY2DuyJBrybgCMyLP9Xr1NWc0lpuAVRk2tAx015Y1th11PuxbrGjw7bE5RBq7uPc1rbp6t21qfCC3BVbRTy59TL4Xb-v5R7JcvX_OX5eJE1KyJDd54blB1OgLiZCBKxybaZ9nXAjlVAFprg3nyD2iAe0y8NwJlTulpAExJi9n390hq31-SWUvKW2Dpf2_CeXWbpqjnZnTj7w3gLOBa5sYW19cbxnYnqXtYdkelj2zFL9Osmhh |
CitedBy_id | crossref_primary_10_3390_cells10112913 crossref_primary_10_1515_hsz_2016_0312 crossref_primary_10_3390_cells12141830 crossref_primary_10_1186_s12885_022_09275_z crossref_primary_10_2217_nnm_2017_0223 crossref_primary_10_1093_jnen_nlx121 |
Cites_doi | 10.1038/modpathol.3800995 10.1200/JCO.2009.26.3061 10.1056/NEJMoa1009290 |
ContentType | Journal Article |
Copyright | Copyright: © 2016 Surgical Neurology International 2016 |
Copyright_xml | – notice: Copyright: © 2016 Surgical Neurology International 2016 |
DBID | AAYXX CITATION 5PM |
DOI | 10.4103/2152-7806.185781 |
DatabaseName | CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2152-7806 |
EndPage | S480 |
ExternalDocumentID | 10_4103_2152_7806_185781 |
GroupedDBID | --- 3V. 53G 5VS 7X7 8FI 8FJ 8G5 AAYXX ABDBF ABJNI ABUWG ABXLX ACGFO ACGFS ACIHN ADBBV ADRAZ AEAQA AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BENPR BPHCQ BVXVI CCPQU CITATION DIK DWQXO E3Z EMOBN ESX F5P FRJ FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HMCUK HYE IAO IHR IL9 KQ8 M2O M48 M~E O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC RMW RNS RPM UKHRP W3E 5PM |
ID | FETCH-LOGICAL-c3551-d9dfe29aa7aef5a0b0cfc147edb2336c6f08d7922a2eaa907cb0e2c36dc665903 |
IEDL.DBID | RPM |
ISSN | 2152-7806 2229-5097 |
IngestDate | Tue Sep 17 21:14:42 EDT 2024 Fri Aug 23 02:39:09 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 18 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3551-d9dfe29aa7aef5a0b0cfc147edb2336c6f08d7922a2eaa907cb0e2c36dc665903 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960920/ |
PMID | 27512609 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4960920 crossref_primary_10_4103_2152_7806_185781 |
PublicationCentury | 2000 |
PublicationDate | 2016-00-00 |
PublicationDateYYYYMMDD | 2016-01-01 |
PublicationDate_xml | – year: 2016 text: 2016-00-00 |
PublicationDecade | 2010 |
PublicationPlace | India |
PublicationPlace_xml | – name: India |
PublicationTitle | Surgical neurology international |
PublicationYear | 2016 |
Publisher | Medknow Publications & Media Pvt Ltd |
Publisher_xml | – name: Medknow Publications & Media Pvt Ltd |
References | Abel (key-10.4103/2152-7806.185781-1) 2005 Martineau (key-10.4103/2152-7806.185781-22) 2013 Crino (key-10.4103/2152-7806.185781-7) 2006 Baselga (key-10.4103/2152-7806.185781-3) 2012 Jundt (key-10.4103/2152-7806.185781-17) 2005 Liaw (key-10.4103/2152-7806.185781-20) 1997 Ruvinsky (key-10.4103/2152-7806.185781-29) 2005 Hsieh (key-10.4103/2152-7806.185781-10) 2010 Cho (key-10.4103/2152-7806.185781-5) 2007 Tremblay (key-10.4103/2152-7806.185781-35) 2001 Hütt-Cabezas (key-10.4103/2152-7806.185781-12) 2013 Montesinos-Rongen (key-10.4103/2152-7806.185781-26) 2009 Riemenschneider (key-10.4103/2152-7806.185781-28) 2006 Shaw (key-10.4103/2152-7806.185781-30) 2006 James (key-10.4103/2152-7806.185781-16) 2009 Hudes (key-10.4103/2152-7806.185781-11) 2007 Thoreen (key-10.4103/2152-7806.185781-33) 2012 Thoreen (key-10.4103/2152-7806.185781-34) 2009 Mavrakis (key-10.4103/2152-7806.185781-23) 2008 McBride (key-10.4103/2152-7806.185781-24) 2010 Im (key-10.4103/2152-7806.185781-13) 2002 Inoki (key-10.4103/2152-7806.185781-14) 2002 Laplante (key-10.4103/2152-7806.185781-19) 2012 Lu (key-10.4103/2152-7806.185781-21) 2010 Wagner (key-10.4103/2152-7806.185781-36) 2010 Hoang-Xuan (key-10.4103/2152-7806.185781-9) 2015 Nardella (key-10.4103/2152-7806.185781-27) 2008 key-10.4103/2152-7806.185781-15 key-10.4103/2152-7806.185781-37 Krueger (key-10.4103/2152-7806.185781-18) 2010 key-10.4103/2152-7806.185781-38 Annovazzi (key-10.4103/2152-7806.185781-2) 2009 Choe (key-10.4103/2152-7806.185781-6) 2003 McCormack (key-10.4103/2152-7806.185781-25) 2011 Drakos (key-10.4103/2152-7806.185781-8) 2008 Chan (key-10.4103/2152-7806.185781-4) 2004 Shimobayashi (key-10.4103/2152-7806.185781-31) 2014 Zoncu (key-10.4103/2152-7806.185781-39) 2011 Stocker (key-10.4103/2152-7806.185781-32) 2003 |
References_xml | – start-page: 671 volume-title: Anti-oncogenic potential of the eIF4E-binding proteins year: 2013 ident: key-10.4103/2152-7806.185781-22 publication-title: Oncogene contributor: fullname: Martineau – start-page: 1236 volume-title: Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: Biallelic inactivation of TSC1 or TSC2 leads to mTOR activation year: 2004 ident: key-10.4103/2152-7806.185781-4 publication-title: J Neuropathol Exp Neurol contributor: fullname: Chan – start-page: 648 volume-title: TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling year: 2002 ident: key-10.4103/2152-7806.185781-14 publication-title: Nat Cell Biol contributor: fullname: Inoki – start-page: e322 volume-title: Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: Guidelines from the European Association for Neuro-Oncology year: 2015 ident: key-10.4103/2152-7806.185781-9 publication-title: Lancet Oncol contributor: fullname: Hoang-Xuan – start-page: 249 volume-title: Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E year: 2010 ident: key-10.4103/2152-7806.185781-10 publication-title: Cancer Cell contributor: fullname: Hsieh – start-page: 2271 volume-title: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma year: 2007 ident: key-10.4103/2152-7806.185781-11 publication-title: N Engl J Med contributor: fullname: Hudes – start-page: 1801 volume-title: A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa} B activity in Hodgkin and anaplastic large cell lymphomas year: 2005 ident: key-10.4103/2152-7806.185781-17 publication-title: Blood contributor: fullname: Jundt – start-page: 21 volume-title: mTOR: From growth signal integration to cancer, diabetes and ageing year: 2011 ident: key-10.4103/2152-7806.185781-39 publication-title: Nat Rev Mol Cell Biol contributor: fullname: Zoncu – start-page: 835 volume-title: Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: Targeting the pathogenic activation of mTORC1 in tumors year: 2010 ident: key-10.4103/2152-7806.185781-36 publication-title: J Clin Oncol contributor: fullname: Wagner – start-page: 2178 volume-title: Tumorigenic activity and therapeutic inhibition of Rheb GTPase year: 2008 ident: key-10.4103/2152-7806.185781-23 publication-title: Genes Dev contributor: fullname: Mavrakis – start-page: 1801 volume-title: Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis year: 2010 ident: key-10.4103/2152-7806.185781-18 publication-title: N Engl J Med contributor: fullname: Krueger – start-page: 274 volume-title: mTOR signaling in growth control and disease year: 2012 ident: key-10.4103/2152-7806.185781-19 publication-title: Cell contributor: fullname: Laplante – start-page: 33 volume-title: Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival year: 2010 ident: key-10.4103/2152-7806.185781-24 publication-title: J Neurooncol contributor: fullname: McBride – start-page: 1595 volume-title: Efficacy and safety of sirolimus in lymphangioleiomyomatosis.N Engl J Med year: 2011 ident: key-10.4103/2152-7806.185781-25 contributor: fullname: McCormack – start-page: e4 volume-title: Mammalian target of rapamycin (mTOR) pathway signalling in lymphomas year: 2008 ident: key-10.4103/2152-7806.185781-8 publication-title: Expert Rev Mol Med contributor: fullname: Drakos – start-page: 2742 volume-title: Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo year: 2003 ident: key-10.4103/2152-7806.185781-6 publication-title: Cancer Res contributor: fullname: Choe – start-page: 2172 volume-title: Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events year: 2008 ident: key-10.4103/2152-7806.185781-27 publication-title: Genes Dev contributor: fullname: Nardella – ident: key-10.4103/2152-7806.185781-15 doi: 10.1038/modpathol.3800995 – start-page: 424 volume-title: Ras, PI (3) K and mTOR signalling controls tumour cell growth year: 2006 ident: key-10.4103/2152-7806.185781-30 publication-title: Nature contributor: fullname: Shaw – start-page: 155 volume-title: Making new contacts: The mTOR network in metabolism and signalling crosstalk year: 2014 ident: key-10.4103/2152-7806.185781-31 publication-title: Nat Rev Mol Cell Biol contributor: fullname: Shimobayashi – start-page: 559 volume-title: Rheb is an essential regulator of S6K in controlling cell growth in Drosophila year: 2003 ident: key-10.4103/2152-7806.185781-32 publication-title: Nat Cell Biol contributor: fullname: Stocker – start-page: 3087 volume-title: mTOR, S6 and AKT expression in relation to proliferation and apoptosis/autophagy in glioma year: 2009 ident: key-10.4103/2152-7806.185781-2 publication-title: Anticancer Res contributor: fullname: Annovazzi – start-page: 7 volume-title: Primary lymphoma of the central nervous system: Just DLBCL or not? year: 2009 ident: key-10.4103/2152-7806.185781-26 publication-title: Blood contributor: fullname: Montesinos-Rongen – start-page: 2199 volume-title: Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis year: 2005 ident: key-10.4103/2152-7806.185781-29 publication-title: Genes Dev contributor: fullname: Ruvinsky – start-page: 379 volume-title: Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma year: 2007 ident: key-10.4103/2152-7806.185781-5 publication-title: Clin Genitourin Cancer contributor: fullname: Cho – start-page: 4250 volume-title: NF2/merlin is a novel negative regulator of mTOR comple×1, and activation of mTORC1 is associated with meningioma and schwannoma growth year: 2009 ident: key-10.4103/2152-7806.185781-16 publication-title: Mol Cell Biol contributor: fullname: James – start-page: 38052 volume-title: Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway.A negative feedback mechanism leading to insulin resistance in skeletal muscle cells year: 2001 ident: key-10.4103/2152-7806.185781-35 publication-title: J Biol Chem contributor: fullname: Tremblay – start-page: 109 volume-title: A unifying model for mTORC1-mediated regulation of mRNA translation year: 2012 ident: key-10.4103/2152-7806.185781-33 publication-title: Nature contributor: fullname: Thoreen – start-page: 3287 volume-title: Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis year: 2010 ident: key-10.4103/2152-7806.185781-21 publication-title: Cancer Res contributor: fullname: Lu – start-page: 341 volume-title: Lhermitte-Duclos disease: A report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTORpathway year: 2005 ident: key-10.4103/2152-7806.185781-1 publication-title: J Neuropathol Exp Neurol contributor: fullname: Abel – start-page: 1604 volume-title: Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target year: 2013 ident: key-10.4103/2152-7806.185781-12 publication-title: Neuro Oncol contributor: fullname: Hütt-Cabezas – start-page: 5618 volume-title: AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling year: 2006 ident: key-10.4103/2152-7806.185781-28 publication-title: Cancer Res contributor: fullname: Riemenschneider – ident: key-10.4103/2152-7806.185781-37 doi: 10.1200/JCO.2009.26.3061 – ident: key-10.4103/2152-7806.185781-38 doi: 10.1056/NEJMoa1009290 – start-page: 520 volume-title: Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer year: 2012 ident: key-10.4103/2152-7806.185781-3 publication-title: N Engl J Med contributor: fullname: Baselga – start-page: 6356 volume-title: Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells year: 2002 ident: key-10.4103/2152-7806.185781-13 publication-title: Oncogene contributor: fullname: Im – start-page: 1345 volume-title: The tuberous sclerosis complex year: 2006 ident: key-10.4103/2152-7806.185781-7 publication-title: N Engl J Med contributor: fullname: Crino – start-page: 64 volume-title: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome year: 1997 ident: key-10.4103/2152-7806.185781-20 publication-title: Nat Genet contributor: fullname: Liaw – start-page: 8023 volume-title: An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1 year: 2009 ident: key-10.4103/2152-7806.185781-34 publication-title: J Biol Chem contributor: fullname: Thoreen |
SSID | ssj0000331109 |
Score | 2.0924244 |
SourceID | pubmedcentral crossref |
SourceType | Open Access Repository Aggregation Database |
StartPage | 475 |
SubjectTerms | Surgical Neurology International: Neuro-Oncology |
Title | mTORC1 signaling in primary central nervous system lymphoma |
URI | https://pubmed.ncbi.nlm.nih.gov/PMC4960920 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZoJxYEAkR5yQMLgxvHjzgREyqtuvAQFIktcmxHVGpCBXTg33OXpKhdmaNLnO8U353z3XeEXGmfGW6tY6HwGVNOKZZhF4iWQUI24aR2eOA2fTEPb-ndGGVy9LoXpiHtu2I-rBfVsJ6_N9zKZeWiNU8serofKZRJEzzqkR7khhslerP9wjPihtqBo6oZBETT_p5UMZcRjnFlJuXJEEWQUhwUIwwEvQQZiRuRaZshuRFyJvtkr8sV6W27pgOyE-pDclPNHp9HMUXihcVecjqv6bLVjKDdjWgNOwCU9LTVaaaLH_DZR2WPyOtkPBtNWTcBgQFIOmY-82UQmbXGhlJbXnBXuliZ4AshZeKSkqfeZEJYEayFOtcVPAgnE--SRGdcHpN-_VGHE0IVfLmxs2BnSsU9L7yAVASqDZfqQpZmQK7Xb593i86hQEDQcgQtR9DyFrQBMVvw_BmgVvX2FXBho1nduez035ZnZBdyle7045z0vz9X4YL0vvzqsvH_L76Hs_o |
link.rule.ids | 230,315,729,782,786,887,4028,27932,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV09T8MwELWgDLDwIUCUTw8sDG4cO44TMaHSqoi2ICgSW-TYjqjUpBWlA_-ec5Kidu1snXJ6iX13zrt3CN0KE0uqlCY2NTEJdBCQ2HWBCG45ZBOaC-0u3HrvcvgZPXacTI5Y9sKUpH2djlvFJG8V46-SWznLtbfkiXmvg3bgZNIY9bbRDuxXSleK9PIAhqf4JbnDDasmEBJl9YMy8Cn33CBXIiMatpwMUuRGxTAJYS90nMSV2LTOkVwJOt2DDd09RPt1lokfquUjtGWLY3Sfj17e2j52lA3lutDxuMCzSm0C1w7gAs6O6WKOK4VnPPmFtz3N1Qn66HZG7R6pZycQgFf4xMQmsyxWSiqbCUVTqjPtB9KalHEe6jCjkZExY4pZpaBC1im1TPPQ6DAUMeWnqFFMC3uGcAB73tcK7GQWUENTwyCJgTpFRyLlmWyiuyVqSe10AqWFAztxYCcO7KQCu4nkGqz_Bk7len0F0CzVrmv0zje2vEG7vdGgn_Sfhs8XaA8ynvoO5RI1fr4X9gptz83iuvyG_gAMCsmA |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELZokRALDwGiPD2wMLhxbCdOxIT6UBFQKigSW-TYjqjUphWlA_-ec5JW7QpzfMrpS-y7sz9_h9BNYGJJldLEpiYmQgtBYncLJOCWQzaheaDdhlvvTfY_onbHyeSsWn0VpH2djpr5eNLMR58Ft3I20d6SJ-YNnlvCyaQx6s1M5tXQNsxZytYK9WIRhjf5BcHDNawmEBZleUgpfMo918yVyIiGTSeFFLl2MUxC6AsdL3EtPm3yJNcCT3f_Hy4foL0q28T35ZBDtGXzI3Q3Gb68tnzsqBvK3UbHoxzPStUJXDmBc1hDpos5LpWe8fgHvvp0oo7Re7czbPVI1UOBAMyBT0xsMstipaSyWaBoSnWmfSGtSRnnoQ4zGhkZM6aYVQoqZZ1SyzQPjQ7DIKb8BNXzaW5PERYw932twE5mghqaGgbJDNQrOgpSnskGul0il1ROJ1BiOMATB3jiAE9KwBtIbkC7MnBq15tPANFC9bpC8OzPltdoZ9DuJk8P_cdztAuJT7WVcoHq318Le4lqc7O4Kn6jX4xVzAA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=mTORC1+signaling+in+primary+central+nervous+system+lymphoma&rft.jtitle=Surgical+neurology+international&rft.au=Nitta%2C+Naoki&rft.au=Nakasu%2C+Satoshi&rft.au=Shima%2C+Ayako&rft.au=Nozaki%2C+Kazuhiko&rft.date=2016&rft.pub=Medknow+Publications+%26+Media+Pvt+Ltd&rft.issn=2229-5097&rft.eissn=2152-7806&rft.volume=7&rft.issue=Suppl+17&rft.spage=S475&rft.epage=S480&rft_id=info:doi/10.4103%2F2152-7806.185781&rft_id=info%3Apmid%2F27512609&rft.externalDBID=PMC4960920 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2152-7806&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2152-7806&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2152-7806&client=summon |